Generation Bio to Present at Cantor Global Healthcare Conference 2024

CAMBRIDGE, Mass., September 12, 2024 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company developing genetic medicines for people with rare and prevalent diseases, announced that Geoff McDonough, MD, President and CEO, will participate in an informal meeting at the Cantor Global Healthcare Conference 2024 on Thursday, September 19, 2024 at 10:20 a.m. ET in New York.

A live webcast of the presentation will be available on the investor section of the company’s website at investors.generationbio.comA replay will be available there for 30 days after the event.